Kyle Rhodehouse

Kyle Rhodehouse

Auto-generated profile, based on publicly available information

Kyle Rhodehouse

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
FSFrancesco R. Simonetti
Francesco R. Simonetti
HZHao Zhang
Hao Zhang
GSGarshasb P. Soroosh
Garshasb P. Soroosh
JDJiayi Duan
Jiayi Duan
KRKyle Rhodehouse
Kyle Rhodehouse
RSRobert F. Siliciano
Robert F. Siliciano
Clonal expansion of infected CD4+ T cells is a major mechanism of HIV-1 persistence and a barrier to achieving a cure. Potential causes are homeostatic proliferation, effects of HIV-1 integration, and interaction with antigens. Here, we show that it is possible to link antigen responsiveness, the full proviral sequence, the integration site, and the T cell receptor β-chain (TCRβ) sequence to examine the role of recurrent antigenic exposure in maintaining the HIV-1 reservoir. We isolated CMV- and Gag-responding CD4+ T cells from 10 treated individuals. Proviral populations in CMV-responding cells were dominated by large clones, including clones harboring replication-competent proviruses. TCRβ repertoires showed high clonality driven by converging adaptive responses. Although some proviruses were in genes linked to HIV-1 persistence (BACH2, STAT5B, MKL1), the proliferation of infected cells under antigenic stimulation occurred regardless of the site of integration. Paired TCRβ and integration site analysis showed that infection could occur early or late in the course of a clone’s response to antigen and could generate infected cell populations too large to be explained solely by homeostatic proliferation. Together, these findings implicate antigen-driven clonal selection as a major factor in HIV-1 persistence, a finding that will be a difficult challenge to eradication efforts.

1 September 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
NMNatalie F. McMyn
Natalie F. McMyn
JVJoseph Varriale
Joseph Varriale
EFEmily J Fray
Emily J Fray
CZCarolin Zitzmann
Carolin Zitzmann
HMHannah MacLeod
Hannah MacLeod
JSJanet M. Siliciano
Janet M. Siliciano
HIV-1 persists in a latent reservoir in resting CD4+ T cells despite antiretroviral therapy (ART). The reservoir decays slowly over the first 7 years of ART (t1/2 = 44 months). However, whether decay continues with long-term ART is unclear. Recent integration site studies indicate gradual selection against inducible, intact proviruses, raising speculation that decades of ART might allow treatment interruption without viral rebound. Therefore, we measured the reservoir in 42 people on long-term ART (mean 22 years) using a quantitative viral outgrowth assay. After 7 years of ART, there was no long-term decrease in the frequency of inducible, replication-competent proviruses but rather an increase with an estimated doubling time of 23 years. Another reservoir assay, the intact proviral DNA assay, confirmed that reservoir decay with t1/2 of 44 months did not continue with long-term ART. The lack of decay reflected proliferation of infected cells. Most inducible, replication-competent viruses (79.8%) had env sequences identical to those of other isolates from the same sample. Thus, although integration site analysis indicates changes in reservoir composition, the proliferation of CD4+ T cells counteracts decay, maintaining the frequency of inducible, replication-competent proviruses at roughly constant levels over the long term. These results reinforce the need for lifelong ART.

15 March 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JWJennifer A. White
Jennifer A. White
FWFengting Wu
Fengting Wu
SYSaif Yasin
Saif Yasin
MMMilica Moskovljevic
Milica Moskovljevic
JVJoseph Varriale
Joseph Varriale
FSFrancesco R. Simonetti
Francesco R. Simonetti
BACKGROUND. Antiretroviral therapy (ART) halts HIV-1 replication, decreasing viremia to below the detection limit of clinical assays. However, some individuals experience persistent nonsuppressible viremia (NSV) originating from CD4+ T cell clones carrying infectious proviruses. Defective proviruses represent over 90% of all proviruses persisting during ART and can express viral genes, but whether they can cause NSV and complicate ART management is unknown. METHODS. We carried an in-depth characterization of proviruses causing NSV in 4 study participants with optimal adherence and no drug resistance. We investigated the impact of the observed defects on 5’-Leader RNA properties, virus infectivity, and gene expression. Integration-site specific assays were used to track these proviruses over time and among cell subsets. RESULTS. Clones carrying proviruses with 5’-Leader defects can cause persistent NSV up to ~103 copies/mL. These proviruses had small, often identical deletions or point mutations involving the major splicing donor site (MSD) and showed partially reduced RNA dimerization and nucleocapsid binding. Nevertheless, they were inducible and produced non-infectious virions containing viral RNA but lacking Envelope. CONCLUSION. These findings show that proviruses with 5’-Leader defects in CD4+ T cell clones can give rise to NSV, affecting clinical care. Sequencing of the 5’-Leader can help understanding failure to completely suppress viremia. FUNDING. Office of the NIH Director and National Institute of Dental & Craniofacial Research, NIH; Howard Hughes Medical Institute; Johns Hopkins University Center for AIDS Research; National Institute for Allergy and Infectious Diseases, NIH, to the PAVE, BEAT-HIV and DARE Martin Delaney collaboratories.

27 August 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
PKPeter Kropp
Peter Kropp
JWJing Wu
Jing Wu
MRMike Reidy
Mike Reidy
SSSanjay Shrestha
Sanjay Shrestha
KRKyle Rhodehouse
Kyle Rhodehouse
AGAndy Golden
Andy Golden
Multiple Mitochondrial Dysfunctions Syndrome 1 (MMDS1) is a rare, autosomal recessive disorder caused by mutations in theNFU1gene. NFU1 is responsible for delivery of iron-sulfur clusters (ISCs) to recipient proteins which require these metallic cofactors for their function. Pathogenic variants ofNFU1lead to dysfunction of its target proteins within mitochondria. To date, 20NFU1variants have been reported and the unique contributions of each variant to MMDS1 pathogenesis is unknown. Given that over half of MMDS1 individuals are compound heterozygous for differentNFU1variants, it is valuable to investigate individual variants in an isogenic background. In order to understand the shared and unique phenotypes ofNFU1variants, we used CRISPR/Cas9 gene editing to recreate exact patient variants ofNFU1in the orthologous gene,nfu-1(formerlylpd-8), inC.elegans. Five mutantC.elegansalleles focused on the presumptive iron-sulfur cluster interaction domain were generated and analyzed for mitochondrial phenotypes including respiratory dysfunction and oxidative stress. Phenotypes were variable between the mutantnfu-1alleles and generally presented as an allelic series indicating that not all variants have lost complete function. Furthermore, reactive iron within mitochondria was evident in some, but not all,nfu-1mutants indicating that iron dyshomeostasis may contribute to disease pathogenesis in some MMDS1 individuals.

1 August 2018 in G3: Genes, Genomes, Genetics
Verified
Journal Article
Open access
PDF file
KRKyle Rhodehouse
Kyle Rhodehouse
KCKatherine Cascino
Katherine Cascino
LALaura Aseltine
Laura Aseltine
APAllegra Padula
Allegra Padula
RWRachel Weinstein
Rachel Weinstein
PWPriscilla M. Van Wynsberghe
Priscilla M. Van Wynsberghe
The Caenorhabditis elegans (C. elegans) heterochronic pathway, which regulates developmental timing, is thought to be an ancestral form of the circadian clock in other organisms. An essential member of this clock is the Period protein whose homolog, lin-42, in C. elegans is an important heterochronic gene. LIN-42 functions as a transcriptional repressor of multiple genes including the conserved lin-4 and let-7 microRNAs. Like other Period proteins, levels of LIN-42 oscillate throughout development. In other organisms this cycling is controlled in part by phosphorylation. KIN-20 is the C. elegans homolog of the Drosophila Period protein kinase Doubletime. Worms containing a large deletion in kin-20 have a significantly smaller brood size and develop slower than wild type C. elegans. Here we analyze the effect of kin-20 on lin-42 phenotypes and microRNA expression. We find that kin-20 RNAi enhances loss-of-function lin-42 mutant phenotypes and that kin-20 mutant worms express lower levels of LIN-42. We also show that kin-20 is important for post-transcriptional regulation of mature let-7 and lin-4 microRNA expression. In addition, the increased level of let-7 found in lin-42(n1089) mutant worms is not maintained after kin-20 RNAi treatment. Instead, let-7 is further repressed when levels of kin-20 and lin-42 are both decreased. Altogether these results suggest that though kin-20 regulates lin-42 and let-7 microRNA, it mainly affects let-7 microRNA expression independently of lin-42. These findings further our understanding of the mechanisms by which these conserved circadian rhythmic genes interact to ultimately regulate rhythmic processes, developmental timing and microRNA biogenesis in C. elegans.

1 October 2018 in Mechanisms of Development
Verified
Journal Article
Closed access
SBSkyler Berardi
Skyler Berardi
AMAlanna McFall
Alanna McFall
ATAmanda Toledo-Hernandez
Amanda Toledo-Hernandez
CCCarolyn Coote
Carolyn Coote
HGHillary Graham
Hillary Graham
PWPriscilla M. Van Wynsberghe
Priscilla M. Van Wynsberghe